相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
The Human FSGS-Causing ANLN R431C Mutation Induces Dysregulated PI3K/AKT/mTOR/Rac1 Signaling in Podocytes
Gentzon Hall et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma
Shuxiong Zeng et al.
SCIENTIFIC REPORTS (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Overexpression of Anillin (ANLN) is correlated with colorectal cancer progression and poor prognosis
Guanghui Wang et al.
CANCER BIOMARKERS (2016)
Lung cancer survival in Germany: A population-based analysis of 132,612 lung cancer patients
Andrea Eberle et al.
LUNG CANCER (2015)
Knockdown of ANLN by lentivirus inhibits cell growth and migration in human breast cancer
Weibing Zhou et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
In silico analysis of expression pattern of a Wnt/β-catenin responsive gene ANLN in gastric cancer
Narayanan Sathiya Pandi et al.
GENE (2014)
Mutations in the Gene That Encodes the F-Actin Binding Protein Anillin Cause FSGS
Rasheed A. Gbadegesin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Metastatic sites and survival in lung cancer
M. Riihimaeki et al.
LUNG CANCER (2014)
Non-small-cell lung cancers: a heterogeneous set of diseases
Zhao Chen et al.
NATURE REVIEWS CANCER (2014)
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Julian R. Molina et al.
MAYO CLINIC PROCEEDINGS (2012)
Number of Metastatic Sites Is a Strong Predictor of Survival in Patients With Nonsmall Cell Lung Cancer With or Without Brain Metastases
Yun Oh et al.
CANCER (2009)
ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway
C Suzuki et al.
CANCER RESEARCH (2005)